{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:25:29Z","timestamp":1792697129472,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["23 2613 Fk"],"award-info":[{"award-number":["23 2613 Fk"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-971390"],"award-info":[{"award-number":["SLS-971390"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["FoUI-981345"],"award-info":[{"award-number":["FoUI-981345"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.survophthal.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T19:08:48Z","timestamp":1727550528000},"page":"38-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"70","author":[{"given":"Gustav","family":"St\u00e5lhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Ermedahl Conradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2024.09.004_bib1","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(84)34088-X","article-title":"Growth rates and doubling times of posterior uveal melanomas","volume":"91","author":"Augsburger","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.09.004_bib2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archopht.1993.01090100090033","article-title":"Vrabec TR: impact of delayed treatment in growing posterior uveal melanomas","volume":"111","author":"Augsburger","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib3","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.survophthal.2024.09.004_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000515559","article-title":"Uveal melanoma: refusal of treatment","volume":"7","author":"Bowen","year":"2021","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archophthalmol.2011.181","article-title":"Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type","volume":"129","author":"Callejo","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma. Growth rate and prognosis","volume":"115","author":"Char","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archopht.1997.01100160056009","article-title":"Collaborative Ocular Melanoma Study Group: Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020477","article-title":"Multicenter external validation of the liverpool uveal melanoma prognosticator online: an OOG collaborative study","volume":"12","author":"Cunha Rola","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.survophthal.2024.09.004_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","article-title":"Does ocular treatment of uveal melanoma influence survival?","volume":"103","author":"Damato","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.survophthal.2024.09.004_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2009.4165.x","article-title":"Does delayed treatment shorten the life of patients with fatal choroidal melanoma?","volume":"87","author":"Damato","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib11","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2024.09.004_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaophthalmol.2014.77","article-title":"Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival","volume":"132","author":"Damato","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib13","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1167\/iovs.16-19654","article-title":"External validation of the liverpool uveal melanoma prognosticator online","volume":"57","author":"DeParis","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.09.004_bib14","first-page":"969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings","volume":"119","author":"Diener-West","year":"2001","journal-title":"COMS Rep No 18 Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.09.004_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archopht.1985.01050070050028","article-title":"Comparison of uveal melanoma growth rates with mitotic index and mortality","volume":"103","author":"Gass","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib17","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-12-4355","article-title":"The model muddle: in search of tumor growth laws","volume":"73","author":"Gerlee","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2024.09.004_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/aqad029","article-title":"Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases","volume":"160","author":"Gill","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib19","doi-asserted-by":"crossref","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2024.09.004_bib20","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.24.00447","article-title":"15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study No. 2 (COOG2.1)","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24","volume":"138","author":"Hawkins","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.survophthal.2024.09.004_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjophthalmol-2020-318658","article-title":"Presumed incipient choroidal melanoma: proposed diagnostic criteria and management","volume":"107","author":"Jouhi","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib24","series-title":"Uveal Melanoma: AJCC Cancer Staging Manual","first-page":"805","author":"Kivel\u00e4","year":"2017"},{"key":"10.1016\/j.survophthal.2024.09.004_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2024.09.004_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101041","article-title":"Metastatic uveal melanoma: the final frontier","volume":"90","author":"Rantala","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.09.004_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000517203","article-title":"Small choroidal melanoma: correlation of growth rate with pathology","volume":"7","author":"Raval","year":"2021","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.survophthal.2024.09.004_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(196111\/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H","article-title":"A biomathematical approach to clinical tumor growth","volume":"14","author":"Schwartz","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2024.09.004_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.09.004_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad097","article-title":"Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death","volume":"7","author":"Stalhammar","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.survophthal.2024.09.004_bib32","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ophtha.2023.11.021","article-title":"Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death","volume":"131","author":"Stalhammar","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.09.004_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ophtha.2023.10.026","article-title":"Improved staging of ciliary body and choroidal melanomas based on estimation of tumor volume and competing risk analyses","volume":"131","author":"Stalhammar","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103652","article-title":"The long-term prognosis of patients with untreated primary uveal melanoma: a systematic review and meta-analysis","volume":"172","author":"Stalhammar","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(02)02270-5","article-title":"Mortality after deferral of treatment or no treatment for choroidal melanoma","volume":"136","author":"Straatsma","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib36","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2024.09.004_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007178","article-title":"Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors","volume":"16","author":"Vaghi","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","article-title":"Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma","volume":"134","author":"Walter","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.09.004_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.62.6.420","article-title":"Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells","volume":"62","author":"Zimmerman","year":"1978","journal-title":"Br J Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:03:39Z","timestamp":1732856619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0039625724001176"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.09.004","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}